KIMMTRAK

NDC 80446-401 · Immunocore Commercial LLC

Generic nameTEBENTAFUSP

Dosage formINJECTION, SOLUTION, CONCENTRATE

RouteINTRAVENOUS

Active ingredient(s)TEBENTAFUSP

Strength100 ug/.5mL

Pharmacologic classBispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC], CD3 Receptor Agonists [MoA], CD3-directed Antibody Interactions [MoA], Glycoprotein 100 Peptide-Human Leukocyte Antigen-directed Antibody Interactions [MoA]

Marketing categoryBLA

Packages

80446-401-01 — 1 VIAL, GLASS in 1 CARTON (80446-401-01) / .5 mL in 1 VIAL, GLASS

Billed under HCPCS

J9274 — Injection, tebentafusp-tebn, 1 microgram Medicare Part B payment limit (ASP + 6%): $228.01

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources